Quotient Company Profile (NASDAQ:QTNT)

About Quotient

Quotient logoQuotient Limited is a commercial-stage diagnostics company. The Company is focused on blood grouping and serological disease screening. Blood grouping involves specific procedures performed at donor or patient testing laboratories to characterize blood, which includes antigen typing and antibody identification. Serological disease screening involves the screening of donor blood for unwanted pathogens. The Company is engaged in the development, manufacturing and commercialization of conventional reagent products for blood grouping. The Company also undertakes product development projects for its original equipment manufacturer (OEM) customers. The Company develops, manufactures and commercializes the products including Antisera products, Reagent Red Blood Cells, Whole Blood Controls and Ancillary products. The Company is developing MosaiQ to characterize donor and patient blood, and serologically screen donor blood for specific viruses.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Diagnostic Substances
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: QTNT
  • CUSIP:
Key Metrics:
  • Previous Close: $5.99
  • 50 Day Moving Average: $6.76
  • 200 Day Moving Average: $8.43
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -16.19
  • P/E Growth: 0.00
  • Market Cap: $86.11M
  • Outstanding Shares: 14,376,000
  • Beta: 1.35
Additional Links:
Companies Related to Quotient:

Analyst Ratings

Consensus Ratings for Quotient (NASDAQ:QTNT) (?)
Ratings Breakdown: 1 Buy Rating
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $28.00 (367.45% upside)

Analysts' Ratings History for Quotient (NASDAQ:QTNT)
Show:
DateFirmActionRatingPrice TargetDetails
6/1/2016Jefferies GroupReiterated RatingBuy$28.00View Rating Details
1/21/2015Robert W. BairdDowngradeOutperform -> Neutral$12.00View Rating Details
(Data available from 8/27/2014 forward)

Earnings

Earnings History for Quotient (NASDAQ:QTNT)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
10/31/2016        
5/23/2016Q4($0.59)($0.41)$5.05 millionViewN/AView Earnings Details
2/8/2016Q316($0.76)($0.48)$4.06 million$4.35 millionViewN/AView Earnings Details
11/2/2015Q216($0.80)($0.25)$4.42 million$4.27 millionViewN/AView Earnings Details
8/3/2015Q116($0.67)($0.60)$4.90 million$4.85 millionViewN/AView Earnings Details
5/18/2015Q415($0.52)($0.77)$4.36 millionViewN/AView Earnings Details
2/4/2015($0.68)($0.51)ViewN/AView Earnings Details
11/3/2014($0.58)($0.82)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Quotient (NASDAQ:QTNT)
Current Year EPS Consensus Estimate: $-2.18 EPS
Next Year EPS Consensus Estimate: $-0.37 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20162($0.69)($0.58)($0.64)
Q2 20161($0.54)($0.54)($0.54)
Q3 20162($0.50)($0.46)($0.48)
Q4 20161($0.63)($0.63)($0.63)
Q1 20171($0.71)($0.71)($0.71)
Q2 20171($0.64)($0.64)($0.64)
Q3 20171($0.44)($0.44)($0.44)
Q4 20171($0.36)($0.36)($0.36)
Q1 20181($0.03)($0.03)($0.03)
Q2 20181($0.30)($0.30)($0.30)
Q3 20181($0.28)($0.28)($0.28)
Q4 20181$0.24$0.24$0.24
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Quotient (NASDAQ:QTNT)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Quotient (NASDAQ:QTNT)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
8/3/2016D J Paul E CowanInsiderBuy45,455$5.50$250,002.50View SEC Filing  
8/3/2016L John WilkersonDirectorBuy180,000$5.50$990,000.00View SEC Filing  
6/9/2016Jeremy StackawitzPresidentSell15,000$10.00$150,000.00View SEC Filing  
6/3/2016Stephen UngerCFOSell14,484$9.99$144,695.16View SEC Filing  
6/2/2016Stephen UngerCFOSell8,516$10.49$89,332.84View SEC Filing  
2/10/2016Zubeen ShroffDirectorBuy222,222$9.00$1,999,998.00View SEC Filing  
6/2/2015Sarah A OconnorDirectorBuy10,000$15.50$155,000.00View SEC Filing  
3/13/2015Stephen UngerInsiderBuy3,000$15.00$45,000.00View SEC Filing  
3/3/2015Jeremy StackawitzPresidentSell30,000$16.80$504,000.00View SEC Filing  
3/2/2015Jeremy StackawitzPresidentSell4,012$16.88$67,722.56View SEC Filing  
2/17/2015Jeremy StackawitzPresidentSell14,140$17.00$240,380.00View SEC Filing  
11/28/2014Galen Partners V LpMajor ShareholderBuy157,895$9.50$1,500,002.50View SEC Filing  
8/7/2014Stephen UngerCFOBuy3,000$9.13$27,390.00View SEC Filing  
4/30/2014Galen Partners V LpMajor ShareholderBuy312,500$8.00$2,500,000.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Quotient (NASDAQ:QTNT)
DateHeadline
capitalcube.com logoQuotient Ltd. :QTNT-US: Earnings Analysis: Q1, 2017 By the Numbers : August 15, 2016 (NASDAQ:QTNT)
www.capitalcube.com - August 15 at 7:24 PM
sg.finance.yahoo.com logoQuotient reports 1Q loss (NASDAQ:QTNT)
sg.finance.yahoo.com - August 9 at 10:13 AM
biz.yahoo.com logoQ1 2017 Quotient Ltd Earnings Release - After Market Close (NASDAQ:QTNT)
biz.yahoo.com - August 8 at 11:45 AM
finance.yahoo.com logoQuotient Limited Announces Closing of Underwritten Offering of Ordinary Shares (NASDAQ:QTNT)
finance.yahoo.com - August 3 at 7:24 PM
finance.yahoo.com logoQuotient Limited to Report First Quarter Fiscal 2017 Financial Results and Host Conference Call (NASDAQ:QTNT)
finance.yahoo.com - August 1 at 8:30 AM
4-traders.com logoQuotient Limited Announces Pricing of Underwritten Offering of Ordinary Shares (NASDAQ:QTNT)
www.4-traders.com - July 29 at 7:11 PM
finance.yahoo.com logoQuotient Prices 2.8 Million Ordinary Shares (NASDAQ:QTNT)
finance.yahoo.com - July 29 at 9:44 AM
finance.yahoo.com logoShould You Get Rid of Quotient Limited (QTNT) Now? (NASDAQ:QTNT)
finance.yahoo.com - June 23 at 8:43 AM
reuters.com logoQuotient Ltd (QTNT.OQ) (NASDAQ:QTNT)
www.reuters.com - June 4 at 9:58 AM
finance.yahoo.com logoQuotient Limited to Participate in Jefferies 2016 Global Healthcare Conference (NASDAQ:QTNT)
finance.yahoo.com - May 31 at 8:30 AM
biz.yahoo.com logoQUOTIENT LTD Files SEC form 10-K, Annual Report (NASDAQ:QTNT)
biz.yahoo.com - May 31 at 6:38 AM
finance.yahoo.com logoQuotient (QTNT) Is in Oversold Territory: What's Next? (NASDAQ:QTNT)
finance.yahoo.com - February 26 at 10:19 AM
finance.yahoo.com logoQuotient (QTNT) Sees Hammer Chart Pattern: Time to Buy? (NASDAQ:QTNT)
finance.yahoo.com - February 17 at 11:06 AM
capitalcube.com logoQuotient Ltd. Earnings Analysis: Q3, 2016 By the Numbers (NASDAQ:QTNT)
www.capitalcube.com - February 16 at 2:02 PM
biz.yahoo.com logoQUOTIENT LTD Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibits (NASDAQ:QTNT)
biz.yahoo.com - February 9 at 4:57 PM
finance.yahoo.com logoEdited Transcript of QTNT earnings conference call or presentation 8-Feb-16 1:30pm GMT (NASDAQ:QTNT)
finance.yahoo.com - February 8 at 9:29 AM
sg.finance.yahoo.com logoQuotient reports 3Q loss (NASDAQ:QTNT)
sg.finance.yahoo.com - February 8 at 7:59 AM
finance.yahoo.com logoQuotient Limited Reports Third Quarter Fiscal 2016 Financial Results (NASDAQ:QTNT)
finance.yahoo.com - February 8 at 7:45 AM
feeds.benzinga.com logoTrader: Quotient's Public Offering Is 'Priced To Work,' Notes Stock could See Upside (NASDAQ:QTNT)
feeds.benzinga.com - February 5 at 5:38 PM
finance.yahoo.com logoQuotient Gears Up for Secondary Offering (NASDAQ:QTNT)
finance.yahoo.com - February 5 at 8:40 AM
finance.yahoo.com logo2:57 am Quotient prices 4,444,445 of ordinary shares at $9.00 per share. (NASDAQ:QTNT)
finance.yahoo.com - February 5 at 2:57 AM
biz.yahoo.com logoQUOTIENT LTD Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits (NASDAQ:QTNT)
biz.yahoo.com - February 3 at 4:11 PM
finance.yahoo.com logoQuotient Limited Announces Proposed Underwritten Offering of Ordinary Shares (NASDAQ:QTNT)
finance.yahoo.com - February 3 at 4:01 PM
finance.yahoo.com logoQuotient Limited to Report Third Quarter Fiscal 2016 Financial Results and Host Conference Call (NASDAQ:QTNT)
finance.yahoo.com - February 1 at 8:00 AM
finance.yahoo.com logoQuotient Limited Announces Positive Serological Disease Screening Results and Provides MosaiQ™ Development Program Update (NASDAQ:QTNT)
finance.yahoo.com - January 11 at 7:01 AM
finance.yahoo.com logoQuotient Limited to Expand Capability of Its MosaiQ™ Next-Generation Transfusion Diagnostics Platform to Include Nucleic Acid Testing (NASDAQ:QTNT)
finance.yahoo.com - January 11 at 7:00 AM
finance.yahoo.com logoQuotient Limited to Participate in J.P. Morgan 2016 Healthcare Conference (NASDAQ:QTNT)
finance.yahoo.com - December 22 at 2:01 PM
capitalcube.com logoQuotient Ltd. Earnings Analysis: Q2, 2016 By the Numbers (NASDAQ:QTNT)
www.capitalcube.com - December 22 at 11:48 AM
biz.yahoo.com logoQUOTIENT LTD Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events (NASDAQ:QTNT)
biz.yahoo.com - December 9 at 4:45 PM
finance.yahoo.com logoQuotient Limited Announces Plans for New Product Development and Manufacturing Facility Near Edinburgh, Scotland (NASDAQ:QTNT)
finance.yahoo.com - December 9 at 4:31 PM
finance.yahoo.com logoQUOTIENT LTD Financials (NASDAQ:QTNT)
finance.yahoo.com - December 8 at 1:17 PM
noodls.com logoQuotient Limited (Nasdaq: QTNT) to Ring The Nasdaq Stock Market Closing Bell (NASDAQ:QTNT)
www.noodls.com - November 23 at 10:19 AM
finance.yahoo.com logoQuotient Limited to Ring the NASDAQ Stock Market Closing Bell (NASDAQ:QTNT)
finance.yahoo.com - November 23 at 8:00 AM
finance.yahoo.com logoQuotient Limited to Participate in Canaccord Genuity Medical Technology & Diagnostics Forum (NASDAQ:QTNT)
finance.yahoo.com - November 10 at 4:06 PM
biz.yahoo.com logoQUOTIENT LTD Files SEC form 10-Q, Quarterly Report (NASDAQ:QTNT)
biz.yahoo.com - November 4 at 6:34 PM

Social

Quotient (NASDAQ:QTNT) Chart for Saturday, August, 27, 2016


Last Updated on 8/27/2016 by MarketBeat.com Staff